Goldman Sachs Downgrades Biogen (BIIB) to Neutral

March 21, 2019 10:33 AM
Goldman Sachs analyst Terence Flynn downgraded Biogen (NASDAQ: BIIB) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles